Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Research|April 15, 1988
Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in miceR Agah, B Malloy, A Sherrod, et al.
Blood|August 1, 1991
Adoptive transfer of anti-cytomegalovirus effect of interleukin-2-activated bone marrow: potential application in transplantationR Agah, B S Charak, V Chen, et al.
Bone Marrow Transplantation|September 1, 1990
A novel approach to purging of leukemia by activation of bone marrow with interleukin 2B S Charak, B Malloy, R Agah, et al.
Leukemia Research|January 1, 1991
Interaction of various cytokines with interleukin 2 in the generation of killer cells from human bone marrow: application in purging of leukemiaB S Charak, R Agah, D Gray, et al.
Lasers in Surgery and Medicine|January 1, 1994
Rate process model for arterial tissue thermal damage: implications on vessel photocoagulationR Agah, J A Pearce, A J Welch, et al.
American Journal of Diseases of Children (1960)|June 1, 1987
Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections. Routine isolation procedure vs routine procedure supplemented by use of masks and gogglesR Agah, J D Cherry, A J Garakian, et al.
Circulation Research|October 26, 1999
A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expressionG Vassalli, R Agah, R Qiao, et al.
IEEE Transactions on Bio-Medical Engineering|August 1, 1996
Dynamics of temperature dependent optical properties of tissue: dependence on thermally induced alterationR Agah, A H Gandjbakhche, M Motamedi, et al.
Journal of Biological Response Modifiers|April 1, 1988
Therapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factorR Agah, B Malloy, A Sherrod, et al.
Cancer Research|November 1, 1989
Potent graft antitumor effect in natural killer-resistant disseminated tumors by transplantation of interleukin 2-activated syngeneic bone marrow in miceR Agah, B Malloy, M Kerner, et al.
Pageof 3